CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.180
-0.050 (-1.18%)
Nov 21, 2024, 1:53 PM EST - Market open

CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $47.88 million. The enterprise value is $32.92 million.

Market Cap 47.88M
Enterprise Value 32.92M

Important Dates

The next confirmed earnings date is Wednesday, November 27, 2024, before market open.

Earnings Date Nov 27, 2024
Ex-Dividend Date n/a

Share Statistics

CLGN has 11.45 million shares outstanding. The number of shares has increased by 1.97% in one year.

Current Share Class 11.45M
Shares Outstanding 11.45M
Shares Change (YoY) +1.97%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 30.97%
Owned by Institutions (%) 17.60%
Float 7.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 70.30
Forward PS 39.06
PB Ratio 2.34
P/TBV Ratio 2.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 47.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.16.

Current Ratio 6.27
Quick Ratio 6.07
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -61.55% and return on invested capital (ROIC) is -36.23%.

Return on Equity (ROE) -61.55%
Return on Assets (ROA) -33.77%
Return on Capital (ROIC) -36.23%
Revenue Per Employee $9,187
Profits Per Employee -$232,947
Employee Count 75
Asset Turnover 0.02
Inventory Turnover 2.14

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -24.46% in the last 52 weeks. The beta is 0.48, so CLGN's price volatility has been lower than the market average.

Beta (5Y) 0.48
52-Week Price Change -24.46%
50-Day Moving Average 4.37
200-Day Moving Average 5.03
Relative Strength Index (RSI) 52.10
Average Volume (20 Days) 16,494

Short Selling Information

Short Interest 15,431
Short Previous Month 14,451
Short % of Shares Out 0.20%
Short % of Float n/a
Short Ratio (days to cover) 1.38

Income Statement

In the last 12 months, CLGN had revenue of $689,000 and -$17.47 million in losses. Loss per share was -$1.53.

Revenue 689,000
Gross Profit -1.44M
Operating Income -18.41M
Pretax Income -7.50M
Net Income -17.47M
EBITDA -17.31M
EBIT -18.41M
Loss Per Share -$1.53
Full Income Statement

Balance Sheet

The company has $18.92 million in cash and $3.39 million in debt, giving a net cash position of $15.54 million or $1.36 per share.

Cash & Cash Equivalents 18.92M
Total Debt 3.39M
Net Cash 15.54M
Net Cash Per Share $1.36
Equity (Book Value) 20.73M
Book Value Per Share 1.81
Working Capital 17.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.75 million and capital expenditures -$756,000, giving a free cash flow of -$3.51 million.

Operating Cash Flow -2.75M
Capital Expenditures -756,000
Free Cash Flow -3.51M
FCF Per Share -$0.31
Full Cash Flow Statement

Margins

Gross Margin -209.43%
Operating Margin -2,671.26%
Pretax Margin -2,535.70%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -31.90%

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.97%
Shareholder Yield -1.97%
Earnings Yield -36.06%
FCF Yield -7.24%

Analyst Forecast

The average price target for CLGN is $12.50, which is 199.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.50
Price Target Difference 199.04%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.

Last Split Date Nov 21, 2016
Split Type Reverse
Split Ratio 0.6666666:1

Scores

CLGN has an Altman Z-Score of -0.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.25
Piotroski F-Score 1